Abstract:Doxorubicin (Adriamycin) is an anthracycline, a class known for containing the most effective and widely used anti-blastic agents. Doxorubicin’s prolonged use, however, is severely limited by the irreversible and dose-dependent cardiotoxic side effects it causes. Two substances, l-carnitine and coenzyme Q10 (ubiquinone), have long been known to mitigate its cardiac risks.1,2 Coenzyme Q10, an essential component of the electron transport system and a potent intracellular antioxidant, appears to prevent damage to cardiac mitochondria and may also enhance anticancer effects.3 l-carnitine’s interaction with cardiolipin, which modifies membrane permeability and protects mitochondrial function, may explain its inhibition of doxorubicin-induced cardiotoxicity.4 Oral l-carnitine at a dose of 4 g daily for seven days significantly improved Functional Assessment of Cancer Therapy-Fatigue (FACT-F) scores in 50 patients with low plasma carnitine levels who received cisplatin (Platinol, Bristol-Myers Squibb) or ifosfamide-based regimens (American Pharmaceutical Partners).5 “I think it’s a crime that women are put on Adriamycin without these two,” Dr. Alschuler commented. Among other substances with effects on doxorubicin use, green tea has been shown to increase doxorubicin concentrations in tumors (but not in heart or liver tissue). Curcumin use with doxorubicin is contraindicated.6 Melatonin offers both cardiac protection and improved antitumor activity, primarily inhibition of proliferating estrogen receptor alpha–positive MCF-7 breast cancer cells. Dr. Alschuler further noted that beyond doxorubicin, added benefits with coadministration of natural agents may be gained for cyclophosphamide (Cytoxan, Bristol-Myers Squibb), docetaxel (Taxotere, Sanofi-Aventis), and paclitaxel (Taxol, Bristol-Myers Squibb); carboplatin (Paraplatin, Bristol-Myers Squibb), fluorouracil (5-FU), and capecitabine (Xeloda, Roche); and tamoxifen citrate (Nolvadex, AstraZeneca). Peripheral neuropathy is a common side effect of chemotherapy with paclitaxel. Among patients experiencing paclitaxel-induced peripheral neuropathy, l-glutamine (10 g orally three time daily for four days starting 24 hours after completion of therapy with paclitaxel) produced significant reductions in the severity of dysesthesias and numbness (P < 0.05). Significant reductions were also observed in motor weakness (P = 0.04), gait deterioration (P = 0.16), and interference with activities of daily living (P = 0.001).7 Vitamin E showed benefit in a small trial among cancer patients receiving paclitaxel, cisplatin, or their combination. Neurotoxicity was reported in 25% of patients receiving vitamin E at 600 mg/day and in 73.3% of controls (P = 0.019).8 Among agents included in Dr. Alschuler’s list for patients receiving conventional chemotherapy were ginkgo biloba, vitamin E, and l-carnitine for patients receiving carboplatin/cisplatin; fish oil, curcumin, and green tea for patients receiving 5-fluorouracil (5-FU) with leucovorin calcium or capecitabine; and riboflavin, niacin, coenzyme Q10, and melatonin for those receiving tamoxifen. Dr. Alschuler emphasized that unlike metastatic breast cancer, early breast cancer is “basically curable.” She concluded: “Early breast cancer is the time to treat aggressively with both conventional and natural agents.” Dr. Alschuler provides further detail about integrative treatment of breast cancer in her book.9

Integrative healthcare symposium: cancer and chronic lyme disease.

Fungal Fermentation Improves the Nutritional Quality, Flavor Characteristic and Physicochemical Property of Highland Barley Bran

Preparation of potential organic fertilizer rich in γ-polyglutamic acid via microbial fermentation using brewer's spent grain as basic substrate

Feed nutritional value of brewers’ spent grain residue resulting from protease aided protein removal

Cell kinetic studies of endothelial cells in the adenocarcinoma EO 771 and the effect of cyclophosphamide

Fermented Brewers’ Spent Grain Containing Dextran and Oligosaccharides as Ingredient for Composite Wheat Bread and Its Impact on Gut Metabolome In Vitro

Impact of gastrointestinal digestion simulation on brewer's spent grain green extracts and their prebiotic activity

Integrated Metabolomics and Metagenomics Unveiled Biomarkers of Antioxidant Potential in Fermented Brewer's Grains

Brewer’s Spent Grain Enhanced the Recovery of Potential Probiotic Strains in Fermented Milk After Exposure to In Vitro-Simulated Gastrointestinal Conditions

Evaluating the potential of Bacillus subtilis fermented okara as a functional food ingredient through in vitro digestion and fermentation

[Effect of 4 weeks of training on the limit time at VO2 max].

Recent advances in microbial high-value utilization of brewer's spent grain

Bilateral Congenital Posterior Capsular Defects and Ectopic Cataracts.

Prebiotic potential of spent brewery grain - In vitro study

Lactic Acid Fermentation as a Valorising Agent for Brewer’s Spent Yeast—Improving the Sensory Quality and Nutritional Potential

Production of single cell protein from brewer's spent grain through enzymatic saccharification and fermentation enhanced by ammoniation pretreatment

Practice-Based Research

Brewer's spent grain as a self-sufficient feedstock for homofermentative production of optically pure L-lactic acid using Lactobacillus rhamnosus

Fermentation as a Tool to Revitalise Brewers' Spent Grain and Elevate Techno-Functional Properties and Nutritional Value in High Fibre Bread

Microbial Fermentation of the Water-Soluble Fraction of Brewers’ Spent Grain for the Production of High-Value Fatty Acids

Synergistic Ball Milling–Enzymatic Pretreatment of Brewer's Spent Grains to Improve Volatile Fatty Acid Production through Thermophilic Anaerobic Fermentation